Dupont Capital Management’s Usana Health Sciences USNA Stock Holding History

Dupont Capital Management’s Portfolio USNA Stock Details USNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,137	Closed	-$64K	–	1531
2022 Q3	$64K	Sell	1,137 -447	-28%	-$29.5K	﹤0.01%	1129
2022 Q2	$115K	Hold	1,584	–	–	0.01%	1155
2022 Q1	$126K	Sell	1,584 -141	-8%	-$12.7K	0.01%	1215
2021 Q4	$175K	Sell	1,725 -688	-29%	-$68.6K	0.01%	1164
2021 Q3	$222K	Sell	2,413 -342	-12%	-$32.9K	0.01%	1207
2021 Q2	$282K	Hold	2,755	–	–	0.01%	1218
2021 Q1	$269K	Sell	2,755 -566	-17%	-$51.5K	0.01%	1180
2020 Q4	$256K	Sell	3,321 -248	-7%	-$19.2K	0.01%	1088
2020 Q3	$263K	Sell	3,569 -240	-6%	-$19.3K	0.01%	1024
2020 Q2	$280K	Sell	3,809 -341	-8%	-$26.7K	0.01%	995
2020 Q1	$240K	Sell	4,150 -3,393	-45%	-$236K	0.01%	954
2019 Q4	$593K	Sell	7,543 -2,093	-22%	-$154K	0.01%	756
2019 Q3	$659K	Sell	9,636 -1,034	-10%	-$69.4K	0.02%	663
2019 Q2	$848K	Sell	10,670 -6,888	-39%	-$546K	0.02%	591
2019 Q1	$1.47M	Sell	17,558 -9,412	-35%	-$982K	0.03%	437
2018 Q4	$3.17M	Sell	26,970 -14,706	-35%	-$1.7M	0.08%	248
2018 Q3	$5.02M	Buy	41,676 +22,052	+112%	+$2.74M	0.11%	168
2018 Q2	$2.26M	Buy	+19,624	New	+$2.15M	0.05%	329

Other funds holding USNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dupont Capital Management's USNA Position: Q4 2022 in Review

Dupont Capital Management sold out of Usana Health Sciences (USNA) in Q4 2022, closing a stake of 1,137 shares — an estimated $64K sold.

Dupont Capital Management first reported a position in USNA in Q2 2018 and held it in 18 quarters. The position peaked at $5.02M in Q3 2018. 167 funds tracked by Wall St. Rank hold USNA as of Q4 2022.

Dupont Capital Management reported no remaining Usana Health Sciences position as of Q4 2022 after selling out during the quarter.
Dupont Capital Management sold 1,137 Usana Health Sciences shares in Q4 2022, an estimated $64K.
Dupont Capital Management first reported a position in Usana Health Sciences in Q2 2018 and held it in 18 quarters.
Dupont Capital Management's Usana Health Sciences position peaked at $5.02M in Q3 2018.
167 funds tracked by Wall St. Rank held Usana Health Sciences as of Q4 2022.

Based on Dupont Capital Management's 13F filing for Q4 2022, filed 26 Jan 2023.